RapidArc Dynamic improves pelvic organ sparing versus VMAT in endometrial boost planning
In 30 endometrial cancer cases, RapidArc Dynamic improved pelvic OAR sparing and dose fall-off compared with VMAT, but required more monitor units.
In 30 endometrial cancer cases, RapidArc Dynamic improved pelvic OAR sparing and dose fall-off compared with VMAT, but required more monitor units.
Practical pelvic contouring guidance illustrates how cervical involvement, extensive LVSI and bladder motion influence postoperative endometrial cancer target volumes.
Five-year vaginal recurrence was 3.6% without verification imaging, versus 1.6% reported in the separate PORTEC-4a brachytherapy cohort.
Higher vaginal D2cc and target-dose distribution independently predicted grade 1–2 vaginal toxicity after combined external-beam radiotherapy and cuff brachytherapy.
Adding vaginal cuff brachytherapy to whole pelvis radiation therapy was associated with improved overall survival in stage II endometrioid endometrial cancer.